<p>The arrows indicate change in treatment groups of patients from baseline to follow-up. Eight patients changed first line treatment during the period, not illustrated.</p
Change in categorized severity levels of anxiety and depression between baseline and mean follow-up....
<p>Note the significant difference (p < 0.05) between the mean values of WIAUC between the therapy a...
<p>Data are given as numbers with percentages in parenthesis when not otherwise specified. PCI; perc...
<p>Clinical features of patients at baseline and during the course of the treatment.</p
M indicate month(s); VKA vitamin K antagonists. *Note. If there is one symbol in the pattern categor...
<p>‘Change from baseline’ refers to the difference between the baseline value of any pain score and ...
Change in outcome measures from baseline to post-intervention by treatment groups.</p
<p>Patients' baseline characteristics, medical history, and medication use during the follow-up.</p
Baseline characteristics for patients followed up in the control and intervention periods*.</p
<p>Patients baseline characteristics and number of patients per treatment arm in phase II.</p
Baseline characteristics of patients by group of analysis (part 2): Actual intervention among multi-...
<p>A illustration of the variety of LVEDV, LVESV, LVEF, GLS and GCS of AS patients at baseline, 1 we...
Notes: Arrows represent transitions between states and the number of observed transitions is reporte...
<p>(A) Baseline, post-failure and post-retreatment SVR12 changes of Child Pugh Class; (B) baseline a...
<p>The number changes of patients in each score of RVDD at baseline and last follow-up.</p
Change in categorized severity levels of anxiety and depression between baseline and mean follow-up....
<p>Note the significant difference (p < 0.05) between the mean values of WIAUC between the therapy a...
<p>Data are given as numbers with percentages in parenthesis when not otherwise specified. PCI; perc...
<p>Clinical features of patients at baseline and during the course of the treatment.</p
M indicate month(s); VKA vitamin K antagonists. *Note. If there is one symbol in the pattern categor...
<p>‘Change from baseline’ refers to the difference between the baseline value of any pain score and ...
Change in outcome measures from baseline to post-intervention by treatment groups.</p
<p>Patients' baseline characteristics, medical history, and medication use during the follow-up.</p
Baseline characteristics for patients followed up in the control and intervention periods*.</p
<p>Patients baseline characteristics and number of patients per treatment arm in phase II.</p
Baseline characteristics of patients by group of analysis (part 2): Actual intervention among multi-...
<p>A illustration of the variety of LVEDV, LVESV, LVEF, GLS and GCS of AS patients at baseline, 1 we...
Notes: Arrows represent transitions between states and the number of observed transitions is reporte...
<p>(A) Baseline, post-failure and post-retreatment SVR12 changes of Child Pugh Class; (B) baseline a...
<p>The number changes of patients in each score of RVDD at baseline and last follow-up.</p
Change in categorized severity levels of anxiety and depression between baseline and mean follow-up....
<p>Note the significant difference (p < 0.05) between the mean values of WIAUC between the therapy a...
<p>Data are given as numbers with percentages in parenthesis when not otherwise specified. PCI; perc...